RIMAN's K-Beauty Empire: Science and Strategy Fuel APAC Expansion
- $545 million: RIMAN's reported sales in 2023, ranking #22 on the Direct Selling News Global 100 List.
- $3 million: Investment in a new chlorella-based bio-material derived from Jeju Island.
- 20 years: Legal protection secured for RIMAN's proprietary Giant BYoungPool™ ingredient.
Experts would likely conclude that RIMAN's strategic combination of proprietary science-backed ingredients and a robust direct selling network positions it for sustained growth in the competitive K-beauty market.
RIMAN's K-Beauty Empire: Science and Strategy Fuel APAC Expansion
SEOUL, South Korea – April 23, 2026 – K-beauty direct selling firm RIMAN recently gathered 2,000 of its top members and leaders in Macau, not just for celebration, but for a strategic mobilization. The "2026 RIMAN Convention Macau," held from April 17th to 19th under the theme "MADE DIFFERENT," signaled the company's aggressive push to solidify its foothold in the Asia-Pacific region, armed with new scientific innovations and a reinforced network of sellers.
The event brought together representatives from seven key APAC markets—South Korea, Taiwan, Hong Kong, Malaysia, Singapore, the Philippines, and Japan—to The Londoner Macao for three days of intensive training and strategy sessions. While the glittering venue provided a backdrop of success, the core agenda focused on the formidable task of scaling a unified brand identity across diverse markets, a crucial step for a company that has seen meteoric growth since its 2018 founding.
A Network 'Made Different' in Macau
The convention's primary objective was to align local execution with a cohesive global strategy. Executives and regional leaders presented case studies, sharing insights on navigating the unique challenges and opportunities within their respective territories. This collaborative approach is central to the direct selling model, which relies on a motivated and well-informed independent sales force.
For RIMAN, which achieved the #22 rank on the Direct Selling News (DSN) 2023 Global 100 List with reported sales of $545 million, fostering this network is paramount. The direct selling industry in the Asia-Pacific, which accounts for over 40% of the global market, is both lucrative and fraught with challenges, including intense competition and a persistent stigma confusing legitimate businesses with illegal pyramid schemes.
By bringing its top performers together, RIMAN aimed to reinforce its corporate philosophy and provide them with powerful new tools. Youngsu Hwang, the company's Global Chief Sales Officer, stated that the convention's goal was to "strengthen coordination across markets and support long-term growth." The atmosphere reportedly reached a peak during a leadership panel talk and a much-anticipated new product reveal, underscoring the importance of both community and innovation in driving sales.
The $3 Million Bet on Jeju's Green Gold
The most significant announcement from the Macau convention was the unveiling of a new, cutting-edge bio-material. Dr. Hee-sik Kim, CTO of ASK LABS and a researcher at the prestigious Korea Research Institute of Bioscience and Biotechnology (KRIBB), introduced a plant-based ingredient derived from a proprietary chlorella strain found on Jeju Island.
This is no minor product enhancement. The development represents a decade of dedicated research and an investment of KRW 3.9 billion (approximately $3.0 million). The bio-material is rich in carotenoids like lutein and zeaxanthin, compounds known for their powerful antioxidant properties, which are highly sought after in the anti-aging skincare market. This new ingredient is set to debut in RIMAN products later this year, representing a significant bet on science-driven product differentiation.
This commitment to deep research is a cornerstone of the company's strategy. Its parent company, ASK Company, has previously entered into a sponsored research agreement with the Mitragotri Lab at Harvard's John A. Paulson School of Engineering and Applied Sciences, signaling a clear intent to ground its beauty products in verifiable, high-level science. This move helps the company justify its premium positioning in a market flooded with less expensive alternatives.
The Power of Proprietary Plants
The new chlorella bio-material joins RIMAN's existing hero ingredient, Giant BYoungPool™. This proprietary cultivar of Centella Asiatica, a plant celebrated for its soothing and healing properties, is the foundation of the company's flagship Incellderm (ICD) skincare line. During the convention, the ingredient was revisited as a symbol of the brand's heritage and philosophy.
What makes Giant BYoungPool™ a formidable asset is not just its purported efficacy—with larger leaves and higher concentrations of active compounds—but its legal protection. RIMAN has secured 20-year Plant Variety Protection (PVP) for the cultivar from both the Korea Forest Service (granted July 2022) and, critically, the U.S. Department of Agriculture (USDA), with protection beginning in September 2025. This PVP acts like a patent for a plant, granting RIMAN exclusive rights to cultivate and commercialize this specific variety, effectively preventing competitors from using the identical ingredient.
This intellectual property is cultivated at RIMAN's own Smart Farm on Jeju Island, creating a vertically integrated supply chain from seed to serum. This level of control over a unique, legally protected ingredient provides a powerful defense against competitors and a compelling story for its sales force.
Navigating a Crowded K-Beauty Market
RIMAN's strategy of combining a robust direct selling network with proprietary, science-backed ingredients is its answer to the hyper-competitive K-beauty landscape. The company faces pressure from two sides. On one hand are global direct selling giants like Nu Skin, which is heavily investing in digital commerce and its own device-based beauty systems. On the other hand is a vast sea of affordable K-beauty brands like COSRX and Innisfree, which often feature similar trending ingredients, like Centella Asiatica, and are readily available online at lower price points.
By securing patents and investing millions in R&D for exclusive ingredients, RIMAN is building a moat that price-based competitors cannot easily cross. The Macau convention was a clear demonstration of this strategy in action: energizing its human network while simultaneously arming them with products rooted in exclusive science. The upcoming launch of products featuring its new chlorella-derived bio-material will be the next major test of whether this 'Made Different' approach can continue to fuel its ambitious global expansion.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →